 |  |
| ABX | ||
| 1,019.582 | ||
| 6.5800 | 0.0065% | |
| BISNIS-27 | ||
| 539.609 | ||
| -2.9400 | -0.0054% | |
| DBX | ||
| 1,964.911 | ||
| -4.2630 | -0.0022% | |
| ECONOMIC30 | ||
| 123.783 | ||
| -1.5810 | -0.0126% | |
| ESGQKEHATI | ||
| 129.527 | ||
| -0.7630 | -0.0059% | |
| ESGSKEHATI | ||
| 129.174 | ||
| -0.8360 | -0.0064% | |
| I-GRADE | ||
| 211.713 | ||
| -1.1570 | -0.0054% | |
| AUDRP | ||
| 10,376.700 | ||
| 58.2000 | 0.5640% | |
| EURRP | ||
| 16,770.200 | ||
| 47.3000 | 0.2828% | |
| JPYRP | ||
| 103.009 | ||
| 0.9760 | 0.9566% | |
| SINRP | ||
| 11,860.200 | ||
| 50.8000 | 0.4302% | |
| USDRP | ||
| 15,920.000 | ||
| 60.0000 | 0.3783% | |
Penelitian terhadap vaksin nasional COVID-19, Vaksin Merah Putih, terus berlanjut, salah satunya oleh tim peneliti Universitas Airlangga bersama PT Biotis Pharmaceutical Indonesia. Penelitian vaksin telah memasuki uji praklinis tahap II.
